Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Silverman

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Contemporary Clinical Trials|December 20, 2022
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trialJulie H Levison, David Krane, Karen Donelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)Seema A Khan, Fengmin Zhao, Lori J Goldstein, et al.
Breast Cancer Research and Treatment|April 28, 2021
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimensBeverly Moy, Mafalda Oliveira, Cristina Saura, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2021
Biosimilar strategic implementation at a large health systemIndrani Kar, Margaret Kronz, Evelina Kolychev, et al.
Administration and Policy in Mental Health|November 8, 2023
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the PandemicVicki Fung, Julie H Levison, Anna Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Disability and Health Journal|June 15, 2024
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilitiesJulie H Levison, Vicki Fung, Anna Wilson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyCrystal S Denlinger, Tara Sanft, K Scott Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyCrystal S Denlinger, Tara Sanft, K Scott Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
NCCN Guidelines Insights: Survivorship, Version 1.2016Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Contemporary Clinical Trials|December 20, 2022
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trialJulie H Levison, David Krane, Karen Donelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)Seema A Khan, Fengmin Zhao, Lori J Goldstein, et al.
Breast Cancer Research and Treatment|April 28, 2021
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimensBeverly Moy, Mafalda Oliveira, Cristina Saura, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2021
Biosimilar strategic implementation at a large health systemIndrani Kar, Margaret Kronz, Evelina Kolychev, et al.
Administration and Policy in Mental Health|November 8, 2023
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the PandemicVicki Fung, Julie H Levison, Anna Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
Disability and Health Journal|June 15, 2024
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilitiesJulie H Levison, Vicki Fung, Anna Wilson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyCrystal S Denlinger, Tara Sanft, K Scott Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyCrystal S Denlinger, Tara Sanft, K Scott Baker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
NCCN Guidelines Insights: Survivorship, Version 1.2016Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, et al.
Pageof 4